Dr. Michelle Reillo to Address the NY State CBD Educational Series: CBD and Implications for Health, The Cannabinoid Manual
(firmenpresse) - ATLANTA, GA -- (Marketwired) -- 01/15/15 -- . (OTC PINK: DGRI) (the "Company") () today announced that the author of The Cannabinoid Manual, Dr. Michelle Reillo will be a featured speaker at the New York State CBD Educational Series. The event, hosted by New York State CBD, will include physicians, researchers, and scientists, participating in a leading edge discussion of the role of Cannabidiol in healthcare.
The event will be held at The New School at 66 West 12th Street in New York City on February 4, 2015 at 10A.M. This is the inaugural forum of four symposia that will be held in 2015 in New York to raise awareness of Cannabidiol. Attendance is limited to 468 attendees for this two-hour presentation, with a live Question and Answer period from the audience to follow. Members of the panel will be available for private interviews by the media afterward.
The Cannabinoid Manual illuminates the newly discovered endocannabinoid system as the central physiological conductor of homeostasis. Dr. Reillo authored the manual in conjunction with the Company, recognizing the educational gap that exists for consumers and is all health care practitioners, regarding CBD.
Said Daniel Hollis, CEO of the Company, "Having participated in the research behind The Cannabinoid Manual, we are pleased to participate in this event, and to support the educational outreach to health care professionals and consumers in New York State." We encourage interested parties to register for the event at .
Forward-Looking Statements
This press release contains forward-looking statements that reflect the Company''s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Dutch Gold Resources, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company''s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company''s expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
For further information, please see or please contact
Daniel Hollis
CEO
Dutch Gold Resources, Inc.
404-981-7424
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.01.2015 - 08:31 Uhr
Sprache: Deutsch
News-ID 1330450
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
ATLANTA, GA
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dr. Michelle Reillo to Address the NY State CBD Educational Series: CBD and Implications for Health, The Cannabinoid Manual
"
steht unter der journalistisch-redaktionellen Verantwortung von
Dutch Gold Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
